[1]岳俊刚,陈 芳.急性淋巴细胞白血病儿童血清miR-1301-3p 和PODXL 表达水平及其临床价值研究[J].现代检验医学杂志,2023,38(06):64-70.[doi:10.3969/j.issn.1671-7414.2023.06.012]
　YUE Jungang,CHEN Fang.Study on the Expression Levels and Clinical Value of Serum miR-1301-3p and PODXL in Children with Acute Lymphoblastic Leukemia[J].Journal of Modern Laboratory Medicine,2023,38(06):64-70.[doi:10.3969/j.issn.1671-7414.2023.06.012]
点击复制

急性淋巴细胞白血病儿童血清miR-1301-3p 和PODXL 表达水平及其临床价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年06期
页码:
64-70
栏目:
论著
出版日期:
2023-11-15

文章信息/Info

Title:
Study on the Expression Levels and Clinical Value of Serum miR-1301-3p and PODXL in Children with Acute Lymphoblastic Leukemia
文章编号:
1671-7414（2023）06-064-07
作者:
岳俊刚; 陈 芳
（江油市第二人民医院检验科，四川江油 621701）
Author(s):
YUE Jungang;  CHEN Fang
（Department of Clinical Laboratory, the Second People’s Hospital of Jiangyou, Sichuan Jiangyou 621701, China）
关键词:
急性淋巴细胞白血病; 微小核糖核酸-1301-3p; 足糖萼蛋白
分类号:
R557.4；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.06.012
文献标志码:
A
摘要:
目的 检测急性淋巴细胞白血病（acute lymphoblastic leukemia, ALL）儿童血清微小核糖核酸（microRNA，miR）-1301-3p，足糖萼蛋白（podocalyxin，PODXL）的表达情况，探讨二者表达水平对儿童急性淋巴细胞白血病的诊断和预后价值。方法 以2017 年1 月～ 2019 年1 月江油市第二人民医院收治的146 例儿童急性淋巴细胞白血病患者为观察组，另选取同期体检的健康儿童100 例作为对照组。采用实时荧光定量PCR（qRT-PCR）技术检测两组血清miR-1301-3p 表达水平；采用酶联免疫吸附（ELISA）法检测两组血清PODXL 表达水平。采用Pearson 相关性分析血清miR-1301-3p 和PODXL 的关系；采用受试者工作特征（ROC）曲线评估患者血清miR-1301-3p 和PODXL 表达对儿童急性淋巴细胞白血病的诊断价值；采用Kaplan-Meier 法分析血清miR-1301-3p 和PODXL 表达对预后的影响；采用COX 回归分析影响儿童急性淋巴细胞白血病的危险因素。结果 观察组血清miR-1301-3p（0.81±0.13）表达水平低于对照组（0.98±0.11），血清PODXL（18.69±4.96 ng/ml）表达水平高于对照组（15.56±4.32 ng/ml），差异具有统计学意义（t=10.710，5.119，均P <0.001）。Pearson 相关性分析显示，观察组血清miR-1301-3p 和PODXL 表达水平呈负相关（r=-0.487，P<0.05）。血清miR-1301-3p 和PODXL联合诊断儿童急性淋巴细胞白血病的AUC（95% CI：0.893 ～ 0.967）大于miR-1301-3p 单独诊断的AUC（95% CI：0.806 ～ 0.910）（Z=2.236，P=0.025）及PODXL 单独诊断的AUC（95%CI：0.665 ～ 0.792）（Z=5.428，P<0.001）。血清miR-1301-3p 表达水平与染色体核型、淋巴结肿大、MLL 基因重排、危险分层、白细胞计数有关（χ2=4.375，5.047，5.773，11.333，12.962，均P < 0.05）。PODXL 表达水平与白细胞计数、危险分层、染色体核型、MLL 基因重排、淋巴结肿大有关（χ2=7.038，7.912，11.440，11.843，23.708，均P < 0.05）。生存分析显示，miR-1301-3p 高表达组患者的总生存率高于miR-1301-3p 低表达组（χ2=10.311，P < 0.05）；PODXL 低表达组的总生存率明显高于PODXL高表达组（χ2=9.419，P < 0.05）。多因素COX回归分析表明，miR-1301-3p 低表达（95%CI：1.061 ～ 3.118）、PODXL 高表达（95% CI：1.030 ～ 2.291）、白细胞计数≥ 50×109/L（95% CI：1.096 ～ 2.943）、中高危险分层（95% CI：1.418 ～ 4.614）和MLL 基因重排阴性（95% CI：1.432 ～ 8.454）是影响儿童急性淋巴细胞白血病不良预后的危险因素（均P < 0.05）。结论 儿童急性淋巴细胞白血病患者血清miR-1301-3p 呈低表达而PODXL呈高表达，二者表达水平对疾病的诊断和预后均具有良好评估效果。
Abstract:
Objective To detect the expression of microRNA (miR) -1301-3p and podocalyxin (PODXL) in serum of children with acute lymphoblastic leukemia(ALL), and explore the diagnostic and prognostic value of the two expression levels in childhood acute lymphoblastic leukemia. Methods From January 2017 to January 2019, 146 children with acute lymphoblastic leukemia patients who were treated in the Second People’s Hospital of Jiangyou were served as the observation group. Another 100 healthy children who underwent physical examination in the hospital during the same period were served as the control group. The expression level of miR-1301-3p in the serum of the two groups was detected by real-time fluorescence quantitative PCR (qRT-PCR) technology, and the expression level of PODXL in serum of the two groups was detected by enzyme-linked immunosorbent assay (ELISA). Pearson correlation was used to analyze the relationship between miR-1301-3p and PODXL expression in serum. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of serum miR-1301-3p and PODXL expression in children with acute lymphoblastic leukemia. Kaplan-Meier method was used to analyze the effect of serum miR-1301-3p and PODXL expression on the prognosis of patients, and COX regression analysis was used to analyze the risk factors affecting acute lymphoblastic leukemia in children. Results The expression level of serum miR-1301- 3p(0.81±0.13) in the observation group was lower than that in the control group (0.98±0.11), the expression level of serum PODXL (18.69±4.96 ng/ml) was higher than that in the control group (15.56±4.32 ng/ml), and the differences were statistically significant(t=10.710, 5.119, all P<0.001). Pearson correlation analysis showed that the expression levels of miR-1301-3p and PODXL in serum of the observation group were negatively correlated (r=-0.487, P<0.05). The AUC(95% CI:0.893 ～ 0.967) of serum miR-1301-3p combined PODXL expression in the diagnosis of childhood acute lymphoblastic leukemia was greater than that of miR-1301-3p alone(95% CI:0.806 ～ 0.910) (Z=2.236, P=0.025) and PODXL alone(95% CI:0.665 ～ 0.792) (Z=5.428, P<0.001). The expression levels of serum miR-1301-3p were associated with karyotype, lymphadenopathy, MLL gene rearrangement, risk stratification and white blood cell count (χ2=4.375, 5.047, 5.773, 11.333, 12.962, all P<0.05). The expression levels of serum PODXL were associated with white blood cell count, risk stratification, karyotype, MLL gene rearrangement and lymphadenopathy(χ2=7.038, 7.912, 11.440, 11.843, 23.708, all P<0.05). Survival analysis showed that the overall survival rate of patients in the miR-1301-3p high expression group was higher than that in the miR-1301-3p low expression group (χ2=10.311, P<0.05)，the overall survival rate in PODXL low expression group was obviously higher than that in the PODXL high expression group (χ2=9.419, P<0.05). Multivariate COX regression analysis showed that low expression of miR-1301-3p(95% CI:1.061 ～ 3.118), high expression of PODXL(95% CI:1.030 ～ 2.291), white blood cell count ≥ 50×109/L(95% CI:1.096 ～ 2.943), medium-high risk stratification(95% CI:1.418 ～ 4.614), and negative MLL gene rearrangement(95% CI:1.432 ～ 8.454) were risk factors for poor prognosis in children with acute lymphoblastic leukemia (all P<0.05). Conclusion The serum miR-1301-3p expression in children with acute lymphoblastic leukemia was low and PODXL is high expression, and the expression levels of both have good evaluation effects on the diagnosis and prognosis of the disease.

参考文献/References:

[1] 郭晓波, 蔺京, 史敏, 等. T 细胞型急性淋巴细胞白血病患者HOX11L2 基因的表达及其临床意义[J].现代检验医学杂志, 2020, 35(5): 9-12. GUO Xiaobo, LIN Jing, SHI Min, et al. Expression and clinical significance of HOX11L2 gene in patients with T cell acute lymphoblastic leukemia[J]. Journal of Modern Laboratory Medicine, 2020, 35(5): 9-12.
[2] 许凤玲, 管贤敏, 温贤浩, 等. 儿童急性淋巴细胞白血病化疗相关严重不良反应的临床分析[J]. 中国当代儿科杂志, 2020, 22(8): 828-833. XU Fengling, GUAN Xianmin, WEN Xianhao, et al. Serious adverse events associated with chemotherapy in children with acute lymphoblastic leukemia[J]. Chinese Journal of Contemporary Pediatrics, 2020, 22(8): 828-833.
[3] 刘睿, 王玉明. 竞争性内源性RNA 在急性髓系白血病中的研究进展[J]. 现代检验医学杂志, 2022,37(3): 198-204. LIU Rui, WANG Yuming. Research progress of competitive endogenous RNA in acute myeloid leukemia[J].Journal of Modern Laboratory Medicine, 2022, 37(3):198-204.
[4] 刘牧, 杨夏茵, 薄海美. miR-27a-3p 调控XIAP 表达对急性T 淋巴细胞白血病Jurkat 细胞增殖和凋亡的影响[J]. 重庆医学, 2021, 50(9): 1446-1450. LIU Mu, YANG Xiayin, BO Haimei. Effects of miR-27a-3p regulating XIAP expression on proliferation and apoptosis of Jurkat cells in acute T lymphocytic leukemia[J]. Chongqing Medicine, 2021, 50(9): 1446-1450.
[5] 沈文翠, 石雨薇. miR-142-3p 靶向HOXA5 对急性B 淋巴细胞白血病细胞增殖、周期阻滞与凋亡作用的研究[J]. 中国实验血液学杂志, 2021, 29(4): 1085-1092. SHEN Wencui, SHI Yuwei. Effect of miR-142-3p targeting HOXA5 on proliferation, cycle arrest and apoptosis of acute B lymphocytic leukemia cells[J]. Journal of Experimental Hematology, 2021, 29(4): 1085-1092.
[6] WU Yun, SHEN Qianwen, CHEN Xiaoyu, et al. MiR-1301-3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor[J]. Oncology Letters, 2020,20(6): 286.
[7] 何梓健. DDX39 及PODXL 蛋白在胃癌中的表达及与病理特征的统计分析[J]. 解放军预防医学杂志,2020, 38(6): 64-66. HE Zijian. The expression of DDX39 and PODXL proteins in gastric cancer and statistical analysis of their pathological characteristics[J]. Journal of Preventive Medicine of Chinese People’s Liberation Army, 2020,38(6): 64-66.
[8] TAMAYO-ORBEGOZO E, AMO L, D?EZ-GARC?A J,et al. Emerging role of podocalyxin in the progression of mature B-cell non-hodgkin lymphoma[J]. Cancers (Basel), 2020, 12(2): 396.
[9] 吴敏媛, 李志刚.“儿童急性淋巴细胞白血病诊疗建议( 第四次修订)”解读[J]. 中华儿科杂志, 2014,52(9): 645-648. WU Minyuan, LI Zhigang. Recommendations for the diagnosis and treatment of acute lymphoblastic leukemia in children(fourth revision)[J]. Chinese Journal of Pediatrics, 2014, 52(9): 645-648.
[10] 朱奕月, 吴日暖, 李霞, 等. 血清miR-922 及miR-506 对儿童急性淋巴细胞白血病诊断及预后判断的价值[J]. 中国当代儿科杂志, 2021, 23(10): 1021-1026. ZHU Yiyue, WU Rinuan, LI Xia, et al. Value of serum miR-922 and miR-506 expression levels in the diagnosis and prognostic assessment of childhood acute lymphoblastic leukemia[J]. Chinese Journal of Contemporary Pediatrics, 2021, 23(10): 1021-1026.
[11] WANG Xueliang, DENG Decheng, YAN Yaping, et al. Genetic variants in m5C modification core genes are associated with the risk of Chinese pediatric acute lymphoblastic leukemia: A five-center case-control study[J]. Front Oncol, 2022, 12: 1082525.
[12] JO H Y, SHIN J H, KIM H Y, et al. Identification of a novel variant in the PHEX gene using targeted gene panel sequencing in a 24-month-old boy with hypophosphatemic rickets[J]. Annals of Pediatric Endocrinology Metabolism, 2020, 25(1): 63-67.
[13] VERNERIS M R, MA Qiufei, ZHANG Jie, et al. Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia [J]. Blood Adv, 2021, 5(23): 5387-5395.
[14] QIAO Dehui, HE Xuemei, YANG Hui, et al. MiR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer[J]. American Journal of Otolaryngology, 2021, 42(2): 102920.
[15] XU Ling, NI Na, GAO Haiyang, et al. MicroRNA-1301-3p promotes the progression of non-small cell lung cancer by targeting Thy-1 and predicts poor prognosis of patients[J]. Oncology Letters, 2021, 21(4):327.
[16] ZHANG Xinxue, REN Zhangyong, XU Junming, et al. MiR-1301-3p inhibits epithelial-mesenchymal transition via targeting RhoA in pancreatic cancer[J]. Journal of Oncology, 2022, 2022: 5514715.
[17] NAGANO H, OGATA S, ITO S, et al. Knockdown of podocalyxin post-transcriptionally induces the expression and activity of ABCB1/MDR1 in human brain microvascular endothelial cells[J]. Journal of Pharmaceutical Sciences, 2022, 111(6): 1812-1819.
[18] HE Siying, DU Wenjie, LI Menglan, et al. PODXL might be a new prognostic biomarker in various cancers:a meta-analysis and sequential verification with TCGA datasets[J]. BMC Cancer, 2020, 20(1): 620.
[19] YAO Huiping, CHEN Rui, YANG Yongxiu, et al. LncRNA BBOX1-AS1 aggravates the development of ovarian cancer by sequestering miR-361-3p to augment PODXL expression[J]. Reproductive Sciences, 2021,28(3): 736-744.
[20] TANIUCHI K, UENO M, YOKOSE T, et al. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients[J]. PLoS One, 2022, 17(3): e0265172.
[21] YU Lan, GAO Yanwei, JI Beibei, et al. CTCF-induced upregulation of LINC01207 promotes gastric cancer progression via miR-1301-3p/PODXL axis[J]. Digestive and Liver Disease, 2021, 53(4): 486-495.

相似文献/References:

[1]郭晓波a,蔺京a,史敏,等.T 细胞型急性淋巴细胞白血病患者HOX11L2 基因的表达及其临床意义[J].现代检验医学杂志,2020,35(05):9.[doi:10.3969/j.issn.1671-7414.2020.05.003]
　GUO Xiao-boa,LIN Jinga,SHI Min,et al.Expression and Clinical Significance of HOX11L2 Gene in Patients with T Cell Acute Lymphoblastic Leukemia[J].Journal of Modern Laboratory Medicine,2020,35(06):9.[doi:10.3969/j.issn.1671-7414.2020.05.003]

备注/Memo

备注/Memo:
基金项目：2020 年度江油市科技计划项目（27）：江油地区0~6 岁健康儿童外周血淋巴细胞亚群调查分析。
作者简介：岳俊刚（1985-），男，本科，主管技师，研究方向：临床血液学，E-mail：umjewp@163.com。
通讯作者：陈芳（1971-）女，本科，主任技师，研究方向：医学微生物，E-mail：405393128@qq.com。
更新日期/Last Update: 2023-11-15